Search Results

There are 7661863 results for: content related to: Treatment of chronic H epatitis B in resource-constrained countries: an economic solution is required

  1. Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 9–17, G.-Q. Wang, Y.-P. Ding and Y.-H. Dong

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12059

  2. You have full text access to this OnlineOpen article
    Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 20, Issue 4, April 2013, Pages: e37–e46, Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski and N. V. Naoumov

    Version of Record online : 27 DEC 2012, DOI: 10.1111/jvh.12025

  3. Telbivudine treatment in chronic hepatitis B: experience from China

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 3–8, H. You and J. Jia

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12058

  4. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China

    Journal of Viral Hepatitis

    Volume 22, Issue 1, January 2015, Pages: 46–54, X. Qi, J.-Y Wang, R.-C Mao and J.-M Zhang

    Version of Record online : 13 FEB 2014, DOI: 10.1111/jvh.12229

  5. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease

    Journal of Viral Hepatitis

    Volume 22, Issue 7, July 2015, Pages: 574–580, E. Cholongitas, T. Vasiliadis, I. Goulis, I. Fouzas, N. Antoniadis, V. Papanikolaou and E. Akriviadis

    Version of Record online : 11 NOV 2014, DOI: 10.1111/jvh.12362

  6. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 58–64, Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou and Y. Han

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12065

  7. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 754–762, G.-R. Han, H.-X. Jiang, X. Yue, Y. Ding, C.-M. Wang, G.-J. Wang and Y.-F. Yang

    Version of Record online : 12 JAN 2015, DOI: 10.1111/jvh.12379

  8. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 52–57, Z. Huang, Z. Zhao, Y. Zheng, L. Peng, C. Lin, H. Deng and Z. Gao

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12064

  9. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 46–51, Y. Li, Y. Zhang, J.-P. Wang, J.-Q. Lian and X.-F. Bai

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12063

  10. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 825–834, G. L.-H. Wong, V. W.-S. Wong and H. L.-Y. Chan

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jvh.12341

  11. Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 725–734, Dr Xiao-Jian Zhou, Dr June Ke, Dr William M. Sallas, Dr Colm Farrell, Dr Douglas L. Mayers and Dr Helen S. Pentikis

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333555

  12. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 873–881, M. Lee, S. Oh, H. J. Lee, T.-S. Yeum, J.-H. Lee, S. J. Yu, H. Y. Kim, J.-H. Yoon, H.-S. Lee and Y. J. Kim

    Version of Record online : 18 DEC 2013, DOI: 10.1111/jvh.12217

  13. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 40–45, Jia-Jie Lu, Kai Liu, Yuan-Ji Ma, Juan Wang, En-Qiang Chen and Hong Tang

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12062

  14. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 65–70, M. Liu, H. Cai and W. Yi

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12066

  15. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 732–743, H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila and A. Trylesinski

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01600.x

  16. Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1436–1446, Dr Fred Poordad, Dr Gillian Zeldin, Dr Stuart I. Harris, Dr June Ke, Dr Limin Xu, Dr Douglas Mayers and Dr Xiao-Jian Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337943

  17. Absence of Food Effect on the Pharmacokinetics of Telbivudine Following Oral Administration in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 3, March 2006, Pages: 275–281, Xiao-Jian Zhou, Deborah M. Lloyd, George C. Chao and Nathaniel A. Brown

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005284849

  18. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy

    Liver Transplantation

    Volume 21, Issue 8, August 2015, Pages: 1066–1075, Ilker Turan, Suna Yapali, Fikret Bademkiran, Timur Kose, Soner Duman, Murat Sozbilen, Fulya Gunsar, Galip Ersoz, Ulus Salih Akarca, Omer Ozutemiz and Zeki Karasu

    Version of Record online : 23 JUN 2015, DOI: 10.1002/lt.24131

  19. Single-Dose and Multiple-Dose Pharmacokinetics and Safety of Telbivudine After Oral Administration in Healthy Chinese Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 999–1007, Dr Pei Hu, Dr Ji Jiang, Dr Hongyun Wang, Mr Keith Pietropaolo, Dr George C. Chao, Dr Nathaniel A. Brown and Dr Xiao-Jian Zhou

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006290623

  20. You have free access to this content
    A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection

    Hepatology

    Volume 40, Issue 3, September 2004, Pages: 719–726, Ching-Lung Lai, Seng Gee Lim, Nathaniel A. Brown, Xiao-Jian Zhou, Deborah M. Lloyd, Yin-Mei Lee, Man-Fung Yuen, George C. Chao and Maureen W. Myers

    Version of Record online : 30 AUG 2004, DOI: 10.1002/hep.20374